Label: KROGER MUCUS RELIEF- guaifenesin tablet

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: OTC monograph final

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated December 29, 2022

If you are a consumer or patient please visit this version.

View All Sections
  • ACTIVE INGREDIENT


    Active ingredient (per tablet)

    Guaifenesin  400mg

  • Purpose

    Expectorant

  • Uses

    • helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus 
    • helps make coughs more productive
  • Warnings

    Ask doctor before use if you have

    • persistent or chronic cough, such as occurs with smoking, asthma, bronchitis or emphysema
    • cough is accompanied by excessive phlegm (mucus)
  • Stop use and ask doctor if

    • Symptoms are accompanied by fever, rash or persistent headache
    • cough persists for more than 1 week or tends to recur

    A persistent cough may be a sign of a serious condition.

  • If pregnant or breast-feeding

    Ask a health professional before use.

  • Keep out of reach of children.

    In case of overdose, get medical help or contact a Poison Control
    Center immediately.

  • Directions

    • Adults and children 12 years of age and over: take 1 tablet every 4 hours as needed
    • Children 6 to 10 under 12 years of age: take 1/2 tablet every 4 hours as needed
    • Children under 6 years of age: consult a doctor    
    Do not exceed 6 doses in a 24 hour period or as directed by a doctor
  • Other directions

    store at 15°-30°C (59°-86°F)

  • Inactive ingredients

    Magnesium Stearate, Microcrystalline Cellulose. Silicon Dioxide, Maltodextrin,  Stearic acid, Povidone K30, Povidone 90F

  • PRINCIPAL DISPLAY PANEL

    image of carton label

    DISTRIBUTED BY THE KROGER COMPANY

    CINCINNATI OHIO 45202

    REV 2/21 GUAF030CT0

  • INGREDIENTS AND APPEARANCE
    KROGER MUCUS RELIEF 
    guaifenesin tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:30142-471
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    Guaifenesin (UNII: 495W7451VQ) (Guaifenesin - UNII:495W7451VQ) Guaifenesin400 mg
    Inactive Ingredients
    Ingredient NameStrength
    MALTODEXTRIN (UNII: 7CVR7L4A2D)  
    STEARIC ACID (UNII: 4ELV7Z65AP)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    POVIDONE K30 (UNII: U725QWY32X)  
    POVIDONE K90 (UNII: RDH86HJV5Z)  
    Product Characteristics
    ColorwhiteScore2 pieces
    ShapeOVALSize17mm
    FlavorImprint Code PH063
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:30142-471-301 in 1 CARTON03/03/2021
    130 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph finalpart34101/27/2021
    Labeler - THE KROGER CO (006999528)
    Registrant - Reese Pharmaceutical Co (004172052)
    Establishment
    NameAddressID/FEIBusiness Operations
    Pharbest557054835manufacture(30142-471)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!